What's Happening?
The U.S. Food and Drug Administration (FDA) has decided to exempt the low-calorie sweetener tagatose from 'added sugar' labeling requirements on U.S. food labels. This decision follows a prolonged campaign
by Virginia-based startup Bonumose, which argued that the classification of tagatose as 'added sugar' was a barrier for food manufacturers. Tagatose, which is nearly as sweet as sugar but contains only 38% of the calories, has been recognized for its health benefits, including improved glycemic control and reduced dental caries risk. The FDA's decision comes after a court ruling in 2024 that found the agency's previous denial of Bonumose's petition to be arbitrary and capricious. The FDA's new stance is expected to increase the use of tagatose in various food and beverage categories, as it is now excluded from 'added sugars' and 'total sugars' declarations on Nutrition Facts labels.
Why It's Important?
The FDA's exemption of tagatose from 'added sugar' labeling is significant for the food industry, particularly for manufacturers looking to offer healthier alternatives to traditional sugars. Tagatose's low glycemic index and prebiotic effects make it an attractive option for consumers seeking products that support gut health and manage blood sugar levels. The decision is likely to spark increased interest and investment in tagatose production, potentially leading to wider availability and lower costs. This could benefit companies like Bonumose and its partners, such as ASR Group and Hershey, who are already involved in tagatose distribution and production. The move also reflects a broader trend towards accommodating innovative food ingredients that offer health benefits, aligning with consumer demand for healthier food options.
What's Next?
Following the FDA's decision, Bonumose plans to increase its tagatose production capacity significantly. The company, which has developed a lower-cost production method using maltodextrin, aims to transition tagatose from a niche product to a mainstream sweetener. This expansion could lead to collaborations with other food manufacturers and distributors, further integrating tagatose into various food and beverage products. Additionally, the FDA's decision may prompt other companies to explore similar exemptions for alternative sweeteners, potentially leading to more innovations in the food industry.
